Literature DB >> 3017207

Deafferentation pain and stimulation of the thalamic sensory relay nucleus: clinical and experimental study.

T Tsubokawa, Y Katayama, T Yamamoto, T Hirayama.   

Abstract

This report summarizes our clinical experience in which the effects of both thalamic sensory relay nucleus (TSRN) and periaqueductal gray (PAG) stimulation were tested in the same series of patients with various forms of pain. The clinical data indicated that neurogenic pain due to deafferentation at the level of the peripheral nerves or the spinal cord was often controlled by TSRN stimulation but not by PAG stimulation. We also review the results of our experimental investigations in cats which were undertaken in an attempt to clarify the neurophysiologic basis of such differential clinical effects of TSRN and PAG stimulation. It appeared that abnormal hyperactivity within the trigeminal medullary dorsal horn following retrogasserian rhizotomy was far more frequently inhibited by TSRN stimulation than by PAG stimulation.

Entities:  

Mesh:

Year:  1985        PMID: 3017207     DOI: 10.1159/000101122

Source DB:  PubMed          Journal:  Appl Neurophysiol


  6 in total

1.  Use of cortical stimulation in neuropathic pain, tinnitus, depression, and movement disorders.

Authors:  Fedor Panov; Brian Harris Kopell
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

Review 2.  Neuropathic pain and deep brain stimulation.

Authors:  Erlick A C Pereira; Tipu Z Aziz
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

3.  Chronic precentral stimulation in trigeminal neuropathic pain.

Authors:  H Ebel; D Rust; V Tronnier; D Böker; S Kunze
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

Review 4.  Brain stimulation in the treatment of chronic neuropathic and non-cancerous pain.

Authors:  Ela B Plow; Alvaro Pascual-Leone; Andre Machado
Journal:  J Pain       Date:  2012-04-07       Impact factor: 5.820

Review 5.  Deep brain stimulation for chronic pain: intracranial targets, clinical outcomes, and trial design considerations.

Authors:  Orion Paul Keifer; Jonathan P Riley; Nicholas M Boulis
Journal:  Neurosurg Clin N Am       Date:  2014-10       Impact factor: 2.509

6.  Current and future options for the management of phantom-limb pain.

Authors:  Helena Knotkova; Ricardo A Cruciani; Volker M Tronnier; Dirk Rasche
Journal:  J Pain Res       Date:  2012-03-07       Impact factor: 3.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.